231 related articles for article (PubMed ID: 4941264)
1. Immunological studies with human neoplasms.
Morton DL
J Reticuloendothel Soc; 1971 Jul; 10(1):137-60. PubMed ID: 4941264
[No Abstract] [Full Text] [Related]
2. Immunological aspects of neoplasia: a rational basis for immunotherapy.
Ann Intern Med; 1971 Apr; 74(4):587-604. PubMed ID: 4927902
[No Abstract] [Full Text] [Related]
3. [Immunology of malignant melanoma].
Bourgoin JJ
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):789-807. PubMed ID: 4559237
[No Abstract] [Full Text] [Related]
4. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
Morton DL; Eilber FR; Malmgren RA
Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
[No Abstract] [Full Text] [Related]
5. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
6. Proceedings: Tumour-specific antigens in melanoma.
Lewis MG
Proc Natl Cancer Conf; 1972; 7():77-83. PubMed ID: 4587663
[No Abstract] [Full Text] [Related]
7. [Immunologic reactions in malignant melanoma of the skin in man].
Veresova OV; Korosteleva TA
Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
[No Abstract] [Full Text] [Related]
8. The role of circulating antibody in the control of metastases.
Lewis MG
J Clin Pathol Suppl (R Coll Pathol); 1974; 7():83-93. PubMed ID: 4598354
[No Abstract] [Full Text] [Related]
9. Immunological changes in cancer patients receiving BCG.
Cochran AJ; Mackie RM; Jackson AM; Ogg LJ; Ross CE
Dev Biol Stand; 1977 Apr 13-15; 38():441-8. PubMed ID: 608535
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic reaction-readiness in malignant melanoma].
Bickhardt R; Kunze J
Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
[No Abstract] [Full Text] [Related]
12. Immunotherapy of human melanomas and sarcomas.
Morton DL
Natl Cancer Inst Monogr; 1972 Dec; 35():375-8. PubMed ID: 4659050
[No Abstract] [Full Text] [Related]
13. Immunologic aspects of cancer.
Sophocles AM; Nadler SH
Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
[No Abstract] [Full Text] [Related]
14. Immunological studies in melanoma patients treated with BCG.
De Vries JE; Rümke P
Br J Cancer Suppl; 1973 Aug; 1():97-102. PubMed ID: 4804294
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated antigens and tumour-host interactions.
Baldwin RW
Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
[No Abstract] [Full Text] [Related]
16. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
17. Immunological studies on malignant melanomas of man.
Romsdahl MM; Cox IS
Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
[No Abstract] [Full Text] [Related]
18. Clinical experiences in immunotherapy of cancer.
Krementz ET; Samuels MS; Wallace JH; Benes EN
Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
[No Abstract] [Full Text] [Related]
19. In vitro methods for assessment of antibody-mediated tumor immunity.
Levy NL; Amos DB; Solovieff GV; dos Reis AP
Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
[No Abstract] [Full Text] [Related]
20. Circulating antibodies in human connective tissue malignancy.
Moore M; Hughes LA
Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
